How can we in India Adopt to these Latest Guidelines


Dr Gurpreet S Wander, Ludhiana    05 January 2018

  1. JNC 8 (2014) threshold and targets higher for age >60 was widely criticized.
  2. Issue of AOBP is important since devices are expensive. The definition and classification of HT does not need to be changed.
  3. Longevity in India is less than in US and same targets cannot be applied for the frail old individuals.
  4. Physicians should be oriented towards reducing risk in high risk individuals.
  5. Two latest guidelines have reacted less strongly to the SPRINT trial than the ACC/AHA. We possibly need to follow this approach.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.